Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less ...
PRINCETON, N.J., July 15 Covance Inc. (NYSE: CVD) today announced it has signed an agreement to sell its Interactive Voice & Web Response Services (IVRS/IWRS) business to Phase Forward (Nasdaq: PFWD).
BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE:LH) today announced that Deborah Keller will succeed Joseph Herring as Chief Executive Officer of ...
In 1Q16, LabCorp’s (LH) contract research organization (or CRO) business, Covance Drug Development, accounted for 30.7% of the company’s total revenues. Covance Drug Development accounted for about 24 ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Laboratory Corp of America Holdings (LH.N) said it would pay $6.1 billion (3.81 billion pounds) for Covance Inc (CVD.N ...
Medical testing firm LabCorp (LH) plans to pay roughly $6.1 billion in cash and stock to buy medical research firm Covance (CVD) in a transaction aimed at creating a healthcare diagnostics giant, the ...
New Jersey-based drug development services company Covance Inc. (CVD) recently divested its antibody services unit to antibodies and reagents developer and manufacturer BioLegend, Inc. However, ...
PRINCETON, N.J., April 20 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) announced today that it has entered into a definitive agreement to acquire the eight ...
Combines Covance's comprehensive drug development capabilities with M2Gen's innovative cancer-focused data warehouse to help accelerate development of targeted therapies for cancer patients Princeton, ...
LabCorp acquired outsourcing company Sciformix and plans to integrate it into its Covance drug-development arm. The terms of the deal were not disclosed. The purchase of Sciformix, which focuses on ...
A Covance Inc. investor contends in a lawsuit that the drug-testing company’s board erred in relying on what the shareholder called Goldman Sachs Group Inc.’s conflict-tainted advice in accepting a $6 ...
Laboratory Corp. of America Holdings has agreed to buy Covance Inc. for about $6.1 billion to add contract research services for drug companies to its offering of medical diagnostic tests, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results